Contract Option Exercises — April 29, 2026

Basilea Pharmaceutica International Ltd secured a $92,501,232 cost-sharing contract from HHS/BARDA on 2024-09-18 for antimicrobials R&D against resistant infections, with options pushing potential to $267.6M through 2035-12-31 and $36.2M outlayed to date.

LJT & Associates' 2016 NASA Goddard award for $94,578,354 in launch support services (ceiling $108.1M) ended in 2019 with only $8.8M outlayed, signaling limited realized revenue from this historical non-competed cost-plus fixed fee deal.

IDEMIA National Security Solutions LLC's 2018 delivery order for $72,032,459 from Department of State (ceiling $74.1M) for visa/passport facial recognition integration runs to 2026-09-29 but has only $18.2M outlayed under firm fixed price terms.

Basilea Pharmaceutica's $92.5M HHS/BARDA R&D contract carries execution risks tied to performance milestones for antimicrobials development through 2031-09-30 or 2035-12-31.

LJT & Associates' $94.6M NASA obligation has only $8.8M outlayed post-2019 end date, indicating high budget realization risk with no evident follow-ons.

IDEMIA's $72M State Dept firm fixed price order exposes high performance risk with only $18.2M outlayed over 8 years to 2026-09-29.

Basilea Pharmaceutica's HHS/BARDA contract offers expansion via unexercised options from $92.5M to $267.6M ceiling for antimicrobials R&D.

IDEMIA National Security Solutions could realize remaining $54M obligation plus options to $74.1M on State Dept facial recognition support.

HHS/BARDA's $92.5M award to Basilea Pharmaceutica for antimicrobials against resistant infections underscores sustained civilian investment in biotech R&D (NAICS 541714) with long horizons to 2035.

Department of State's $72M firm fixed price order to IDEMIA for facial recognition integration provides multi-year visibility in IT software (PSC 7030) despite partial outlays.

{"entity"=>"Basilea Pharmaceutica International Ltd", "reason"=>"$92.5M HHS/BARDA obligation with $36.2M outlayed; potential to $267.6M", "trigger"=>"option exercises toward 2031-09-30 or 2035-12-31"}

{"entity"=>"LJT & Associates, Inc.", "reason"=>"$94.6M NASA obligation with only $8.8M outlayed post-2019 performance end", "trigger"=>"follow-on contracts or outlay updates"}

{"entity"=>"IDEMIA National Security Solutions LLC", "reason"=>"$72M State Dept obligation with $18.2M outlayed through 2026", "trigger"=>"option exercises toward $74.1M ceiling"}